Journal: Biochemistry and Biophysics Reports
Article Title: Exploring the impact of hAMSCs secretome on Panc1 cells via TNF-α/NF-κB (p50/p65)/Caspase 3 signaling pathways: An in vitro study
doi: 10.1016/j.bbrep.2025.102411
Figure Lengend Snippet: Schematic model of NF-κB activation (A). The expression of p-IKK, p-IKKα/β, NF-κB (p50/p65), IκB, and p-IκB proteins was analyzed using Western blot in hAMSCs-treated Panc1 cancer cells (B, C, and D). Actin was used as an internal control (TCL: total cell lysate). The induction of NF-κB (p50/p65) expression in hAMSCs secretome-treated Panc1 cells was measured using an ELISA kit (E and F). Data represent mean ± SD of three independent experiments. ∗p < 0.05 was considered statistically significant. N.S: No significant.
Article Snippet: HAMSCs (Cat No: C10680 , human, female, newborn, spindle-shaped) were obtained from the Iranian Biological Resource Center located in Tehran, Iran, while Panc1 pancreatic cancer cells (NCBI No: C556) were acquired from the Pasteur Institute, also situated in Tehran, Iran.
Techniques: Activation Assay, Expressing, Western Blot, Control, Enzyme-linked Immunosorbent Assay